U.S. Food and Drug Administration (FDA) allows advancement of RAP-219 into registrational trials for focal onset seizures (FOS); accelerated initiation of Phase 3 program expected in the second ...
The shift from the SAVE plan to the new RAP program reshapes student loan repayment, aiming for simplicity and fiscal control ...